These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 23563834)

  • 1. Production and diagnostic application of recombinant domain III of West Nile envelope protein in Brazil.
    Chávez JH; Reis VP; Silva JR; Laure HJ; Rosa JC; Fonseca BA; Figueiredo LT
    Rev Soc Bras Med Trop; 2013; 46(1):97-9. PubMed ID: 23563834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance of immunoglobulin G (IgG) and IgM enzyme-linked immunosorbent assays using a West Nile virus recombinant antigen (preM/E) for detection of West Nile virus- and other flavivirus-specific antibodies.
    Hogrefe WR; Moore R; Lape-Nixon M; Wagner M; Prince HE
    J Clin Microbiol; 2004 Oct; 42(10):4641-8. PubMed ID: 15472323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recovery of West Nile Virus Envelope Protein Domain III Chimeras with Altered Antigenicity and Mouse Virulence.
    McAuley AJ; Torres M; Plante JA; Huang CY; Bente DA; Beasley DWC
    J Virol; 2016 May; 90(9):4757-4770. PubMed ID: 26912625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noninfectious recombinant antigen for detection of St. Louis encephalitis virus-specific antibodies in serum by enzyme-linked immunosorbent assay.
    Purdy DE; Noga AJ; Chang GJ
    J Clin Microbiol; 2004 Oct; 42(10):4709-17. PubMed ID: 15472331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunization of flavivirus West Nile recombinant envelope domain III protein induced specific immune response and protection against West Nile virus infection.
    Chu JH; Chiang CC; Ng ML
    J Immunol; 2007 Mar; 178(5):2699-705. PubMed ID: 17312111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of a recombinant envelope protein subunit antigen for specific serological diagnosis of West Nile virus infection.
    Beasley DW; Holbrook MR; Travassos Da Rosa AP; Coffey L; Carrara AS; Phillippi-Falkenstein K; Bohm RP; Ratterree MS; Lillibridge KM; Ludwig GV; Estrada-Franco J; Weaver SC; Tesh RB; Shope RE; Barrett AD
    J Clin Microbiol; 2004 Jun; 42(6):2759-65. PubMed ID: 15184463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A plant-produced vaccine protects mice against lethal West Nile virus infection without enhancing Zika or dengue virus infectivity.
    Lai H; Paul AM; Sun H; He J; Yang M; Bai F; Chen Q
    Vaccine; 2018 Mar; 36(14):1846-1852. PubMed ID: 29490880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A protective human monoclonal antibody targeting the West Nile virus E protein preferentially recognizes mature virions.
    Goo L; Debbink K; Kose N; Sapparapu G; Doyle MP; Wessel AW; Richner JM; Burgomaster KE; Larman BC; Dowd KA; Diamond MS; Crowe JE; Pierson TC
    Nat Microbiol; 2019 Jan; 4(1):71-77. PubMed ID: 30455471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinguishing West Nile virus infection using a recombinant envelope protein with mutations in the conserved fusion-loop.
    Chabierski S; Barzon L; Papa A; Niedrig M; Bramson JL; Richner JM; Palù G; Diamond MS; Ulbert S
    BMC Infect Dis; 2014 May; 14():246. PubMed ID: 24884467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A DNA vaccine encoding the E protein of West Nile virus is protective and can be boosted by recombinant domain DIII.
    Schneeweiss A; Chabierski S; Salomo M; Delaroque N; Al-Robaiy S; Grunwald T; Bürki K; Liebert UG; Ulbert S
    Vaccine; 2011 Aug; 29(37):6352-7. PubMed ID: 21596075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cloning and expression of an envelope gene of West Nile virus and evaluation of the protein for use in an IgM ELISA.
    Saxena D; Parida M; Rao PV; Kumar JS
    Diagn Microbiol Infect Dis; 2013 Apr; 75(4):396-401. PubMed ID: 23357292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutralising antibodies for West Nile virus in horses from Brazilian Pantanal.
    Pauvolid-Corrêa A; Morales MA; Levis S; Figueiredo LT; Couto-Lima D; Campos Z; Nogueira MF; da Silva EE; Nogueira RM; Schatzmayr HG
    Mem Inst Oswaldo Cruz; 2011 Jun; 106(4):467-74. PubMed ID: 21739036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A monoclonal antibody to DIII E protein allowing the differentiation of West Nile virus from other flaviviruses by a lateral flow assay.
    Rebollo B; Pérez T; Camuñas A; Pérez-Ramírez E; Llorente F; Sánchez-Seco MP; Jiménez-Clavero MÁ; Venteo Á
    J Virol Methods; 2018 Oct; 260():41-44. PubMed ID: 29958922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Live measles vaccine expressing the secreted form of the West Nile virus envelope glycoprotein protects against West Nile virus encephalitis.
    Desprès P; Combredet C; Frenkiel MP; Lorin C; Brahic M; Tangy F
    J Infect Dis; 2005 Jan; 191(2):207-14. PubMed ID: 15609230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection of red-legged partridges (Alectoris rufa) against West Nile virus (WNV) infection after immunization with WNV recombinant envelope protein E (rE).
    Escribano-Romero E; Gamino V; Merino-Ramos T; Blázquez AB; Martín-Acebes MA; de Oya NJ; Gutiérrez-Guzmán AV; Escribano JM; Höfle U; Saiz JC
    Vaccine; 2013 Sep; 31(41):4523-7. PubMed ID: 23933372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production of recombinant NS1 protein and its possible use in encephalitic flavivirus differential diagnosis.
    Lorch MS; Collado MS; Argüelles MH; Rota RP; Spinsanti LI; Lozano ME; Goñi SE
    Protein Expr Purif; 2019 Jan; 153():18-25. PubMed ID: 30125621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A recombinant novirhabdovirus presenting at the surface the E Glycoprotein from West Nile Virus (WNV) is immunogenic and provides partial protection against lethal WNV challenge in BALB/c mice.
    Nzonza A; Lecollinet S; Chat S; Lowenski S; Mérour E; Biacchesi S; Brémont M
    PLoS One; 2014; 9(3):e91766. PubMed ID: 24663075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enzyme-linked immunosorbent assays using recombinant envelope protein expressed in COS-1 and Drosophila S2 cells for detection of West Nile virus immunoglobulin M in serum or cerebrospinal fluid.
    Muerhoff AS; Dawson GJ; Dille B; Gutierrez R; Leary TP; Gupta MC; Kyrk CR; Kapoor H; Clark P; Schochetman G; Desai SM
    Clin Diagn Lab Immunol; 2004 Jul; 11(4):651-7. PubMed ID: 15242936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serologic evidence of West Nile Virus in wild ducks captured in major inland resting sites for migratory waterfowl in South Korea.
    Yeh JY; Park JY; Ostlund EN
    Vet Microbiol; 2011 Dec; 154(1-2):96-103. PubMed ID: 21767922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human monoclonal antibodies against West Nile virus induced by natural infection neutralize at a postattachment step.
    Vogt MR; Moesker B; Goudsmit J; Jongeneelen M; Austin SK; Oliphant T; Nelson S; Pierson TC; Wilschut J; Throsby M; Diamond MS
    J Virol; 2009 Jul; 83(13):6494-507. PubMed ID: 19386704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.